第九次STS-Pedimacs年度报告:儿童心室辅助装置结局与双心室支持作用扩大
该Pedimacs报告分析了2012年9月19日至2024年12月31日1465例儿童心室辅助装置植入患者的结局。先天性心脏病患儿接受VAD植入持续增加(28%),单心室先心病患者移植率和生存率显著低于心肌病患者;双心室支持患者术前危重程度更高且生存率显著低于仅左心室辅助装置植入者。总体队列6个月和1年装置生存率分别为77%和73%,且随时间推移生存率逐步改善。
要点
- 先心病患儿VAD植入持续增加(28%),其中61%为单心室先心病。
- 总体装置生存率6个月77%、1年73%;11-19岁、心肌病及植入式连续流VAD患者生存率最高。
- 双心室支持患者术前危重程度更高,生存率显著低于仅左VAD植入者。
核心结论
- 儿童终末期心衰VAD支持持续增加且结局改善,但不同装置类型患者临床特征和结局存在显著差异。
- 单心室先心病患儿移植率和生存率显著低于心肌病患者,双心室支持患者生存率显著低于仅左VAD植入者。
研究设计与样本
- Pedimacs注册研究分析2012年9月19日至2024年12月31日1465例接受VAD植入的儿童患者结局。
主要发现
- 先心病患儿VAD植入持续增加(28%),其中心肌病患儿93%为扩张型心肌病,先心病患儿61%为单心室先心病。
- 植入式连续流VAD是最常用装置(508例[35%])。
- 总体队列装置生存率6个月77%、1年73%;11-19岁、心肌病及植入式连续流VAD患者生存率最高。
- 单心室先心病患儿移植率和生存率显著低于心肌病患者。
- 2012-2015、2016-2020、2021-2024年间儿童VAD支持生存率逐步改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report provides a comprehensive update on pediatric ventricular assist device (VAD) outcomes, including for those requiring biventricular support. METHODS: Outcomes were analyzed for 1465 patients who underwent VAD implantation from September 19, 2012, to December 31, 2024. RESULTS: Children with congenital heart disease (CHD) undergoing VAD implant continue to increase (28%). For patients with cardiomyopathy, 93% had dilated cardiomyopathy. For those with CHD, 61% had single-ventricle CHD. Implantable continuous VADs were the most commonly implanted devices (508 [35%]). For the overall Pedimacs cohort, survival on device was 77% at 6 months and 73% at 1 year. Survival on the device was greatest among patient ages 11 to 19, those with cardiomyopathy, and those implanted with implantable continuous VADs. Transplant rates and survival were significantly lower for children with single-ventricle CHD compared with cardiomyopathy patients. Successive improvement has occurred in survival among pediatric patients supported on a VAD over time (2012-2015 vs 2016-2020 vs 2021-2024). Patients supported with biventricular devices had a higher preimplant acuity and significantly lower survival than those undergoing only left VAD implantation. CONCLUSIONS: This annual Pedimacs report highlights the continued rise in VAD support for children with end-stage heart failure and with improving outcomes. There are significant differences in clinical characteristics and patient outcomes among patients supported with different device types. This report provides a comprehensive analysis of pediatric patients supported with biventricular support.
引用
- Amdani S, Peng DM, Edelson JB, et al. The Ninth Annual STS-Pedimacs Report: Pediatric Ventricular Assist Device Outcomes and the Expanding Role of Biventricular Support. Ann Thorac Surg. 2026. PMID: 42229777. doi:10.1016/j.athoracsur.2026.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。